Clinical Trial Update: A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of OnabotulinumtoxinA for forehead and glabellar rhytides has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Forehead Rhytides
• Glabellar Rhytides

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Forehead Rhytides, Glabellar Rhytides | Phase 3 | Status: COMPLETED | Results posted: 2017-06-23